Financhill
Back

Deckers Outdoor Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
43

DECK
Deckers Outdoor

Last Price:
$139.34
Seasonality Move:
4.43%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$106.83
Seasonality Move:
8.04%
Sell
43
Deckers Outdoor (DECK) is a Sell

Is Deckers Outdoor a Buy, Sell or Hold?

  • The current Deckers Outdoor [DECK] share price is $139.36. The Score for DECK is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • DECK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DECK Stock Price Chart

What is Deckers Outdoor's stock price today?

  • The Deckers Outdoor share price today is $139.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DECK is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $106.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

DECK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -14.87 Sell
Relative Strength Index (14 RSI): 25.64 Sell
Chaikin Money Flow: 1688927 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (143.97 - 199.47) Sell
Bollinger Bands (100): (159.14 - 205.88) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.25 Sell
Relative Strength Index (14 RSI): 41.97 Sell
Chaikin Money Flow: 469170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.93 - 115.87) Sell
Bollinger Bands (100): (111.92 - 127.28) Sell

DECK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.32 Sell
20-day SMA: 160.53 Sell
50-day SMA: 189.64 Sell
200-day SMA: 169.7 Sell
8-day EMA: 146.12 Sell
20-day EMA: 160.43 Sell
50-day EMA: 176.83 Sell
200-day EMA: 168.31 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.35 Buy
20-day SMA: 109.97 Sell
50-day SMA: 116.57 Sell
200-day SMA: 127.54 Sell
8-day EMA: 106.76 Buy
20-day EMA: 109.7 Sell
50-day EMA: 114.67 Sell
200-day EMA: 122.08 Sell

Deckers Outdoor Earnings Growth & DECK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.66 per share, a decrease next quarter of $2.49 per share, an increase this year of $1.37 per share, and an increase next year of $0.70 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.

Deckers Outdoor Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):